Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
News » Diet drug manufacturer seeks approval for multimillion-dollar national settlement over it's banned diet drug
 

Diet drug manufacturer seeks approval for multimillion-dollar national settlement over it's banned diet drug

Following last year's FDA ban on all dietary supplements containing ephedra, about 300 people so far have filed lawsuits against Metabolife International over it's product called Metabolife 256. The company has requested approval for a multimillion-dollar national settlement for US consumers. The diet pill was consumed by body builders for its stamina increasing effects and dieters for its weight loss properties. However, ephedra was found to be linked to strokes, heart attacks and even deaths.

Source: summary of medical news story as reported by NBC4 TV

Related Disease Topics:

Article Source Details

About: Diet drug manufacturer seeks approval for multimillion-dollar national settlement over it's banned diet drug

Date: 6 January 2005

Source: NBC4 TV

URL: http://www.nbc4.tv/health/4049651/detail.html

Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Kidney stone risk increased by obesity
  • King/Drew hospital allegedly suffers from serious patient safety problems
  • Knee or hip replacement surgery may be a better option than living with the risks of long-term anti-inflammatory use
  • Lack of awareness of Lupus is resulting in deaths
  • Lack of follow-up on x-ray result leads to man's death from cancer
  • Lack of personal action plans is proving a killer for asthma sufferers
  • Lack of response to treatment means more patient monitoring is required when treating patients for depression
  • Lack of sleep influences illnesses
  • Lack of translators at hospital put immigrantís lives at risk
  • Lactoferrin helps prevent bone loss as well as promoting bone growth
  • LADA frequently misdiagnosed as type 2 diabetes
  • Laparoscopic technique reduces pain and recovery time for hysterectomy patients
  • Laser therapy takes over arthritis drugs
  • Last resort leukemia drug receives FDA approval
  • Late diagnosis of ovarian cancer ensures poorer prognosis
  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise